Journal
VACCINES
Volume 9, Issue 7, Pages -Publisher
MDPI
DOI: 10.3390/vaccines9070739
Keywords
influenza; matrix protein 2 ectodomain (M2e); nucleoprotein (NP); universal vaccine; adjuvant
Categories
Funding
- Malaysia Ministry of Higher Education (MoHE) Fundamental Research Grant Scheme [FRGS/1/2017/STG05/UKM/02/9]
Ask authors/readers for more resources
The development of a universal influenza vaccine addresses concerns related to annual reformulation and mismatching with circulating subtypes of current influenza vaccines. It contains conserved antigens for cross-protection against all influenza subtypes, with potential as a candidate for a universal influenza vaccine.
Discovery of conserved antigens for universal influenza vaccines warrants solutions to a number of concerns pertinent to the currently licensed influenza vaccines, such as annual reformulation and mismatching with the circulating subtypes. The latter causes low vaccine efficacies, and hence leads to severe disease complications and high hospitalization rates among susceptible and immunocompromised individuals. A universal influenza vaccine ensures cross-protection against all influenza subtypes due to the presence of conserved epitopes that are found in the majority of, if not all, influenza types and subtypes, e.g., influenza matrix protein 2 ectodomain (M2e) and nucleoprotein (NP). Despite its relatively low immunogenicity, influenza M2e has been proven to induce humoral responses in human recipients. Influenza NP, on the other hand, promotes remarkable anti-influenza T-cell responses. Additionally, NP subunits are able to assemble into particles which can be further exploited as an adjuvant carrier for M2e peptide. Practically, the T-cell immunodominance of NP can be transferred to M2e when it is fused and expressed as a chimeric protein in heterologous hosts such as Escherichia coli without compromising the antigenicity. Given the ability of NP-M2e fusion protein in inducing cross-protective anti-influenza cell-mediated and humoral immunity, its potential as a universal influenza vaccine is therefore worth further exploration.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available